ArticleOrphanet journal of rare diseases2022

Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis.

Ting Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.